Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Aehr Test Systems (AEHR) -- Ignore unavailable to you. Want to Upgrade?

To: jeff f who wrote (46)	11/15/1997 12:29:00 PM
From: ccryder	Read Replies (1) \| Respond to of 128

It's a pup. Too early to take it to the pound. My broker and his analyst think this is a buy. I am down 30% so it is really hard for me too hold on to it. The analyst thinks the potential will be realized by the rest of the market in about 6 months. The company's mid range testing system should really take off. The analyst believes that the test equipment, combined with automation for chip handling, will be the lowest cost, highest throughput system which produces known good dies. The dies can then proceed to customers for custom packaging or to standard packaging. Then the chips can be screened and graded. If I didn't own any, this would be a buy point for a fair shot at a double or more in 18 months. Don't bet the farm on it, though. There are better, longer range plays in the market. Good luck.

To: jeff f who wrote (46)	11/17/1997 12:22:00 AM
From: BullonIDT	Respond to of 128

I've said it before and I'll say it again. This stock is a dog. No value added. BI is the one division that a Semicon would love to eliminate. I find it very hard for a co to invest capital in an operation such as BI especially that lots of hardware have been built in the past using a Rel-in config as opposed to a Aehr test config. Besides, they attached their name with the Dram makers in their IPO release. Well, whaere are the Dram makers now??? Anyway, the Aehr approach is out of the mainstream. I would love to short this stock had it been more liquid.